AMN / AMN Healthcare Services, Inc. - SEC-Einreichungen, Jahresbericht, Proxy Statement

DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 AMN Healthcare Services, Inc., a Delaware corporation, has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.01 per share (“common stock”). References herein to the “Company,” “we,” “us”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2026 RESULTS Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million; GAAP income of $1.59/share and adjusted EPS of $2.10

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2026 RESULTS Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million; GAAP income of $1.59/share and adjusted EPS of $2.10 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2026 financial results. Financ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2026 AMN HEALTHCARE SERVICES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2026 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2026 AMN HEALTHCARE SERVICES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2026 AMN HEALTHCARE SERVICES, INC.

As filed with the Securities and Exchange Commission on May 4, 2026

As filed with the Securities and Exchange Commission on May 4, 2026 Registration No.

Table 1: Newly Registered Securities

Calculation of Filing Fee Tables S-8 AMN HEALTHCARE SERVICES INC Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

Amendment No. 1 to the AMN Healthcare 2025 Equity Plan

Exhibit 10.1 Amendment No. 1 to the AMN Healthcare 2025 Equity Plan This Amendment No. 1 (this “Amendment”) amends the AMN Healthcare 2025 Equity Plan (the “Plan”), maintained by AMN Healthcare Services, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined in this Amendment shall have meanings set forth in the Plan. WHEREAS, the Company desires to amend the Plan to

ARS

2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 2025 Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual Report Annual ReportThe AMN team made significant progress in 2025 toward our mission of empowering the future of care despite having to navigate industry conditions that caused fluctuations in demand and profitability.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy

Exhibit 97.1 AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy In accordance with the applicable rules of The New York Stock Exchange (the “NYSE Rules”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) has adopted this Policy to provide for the recovery of awarded Incentive-Bas

AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT

Exhibit 10.51 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date:     Grantee:     Units Granted:      THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S E T H: WHEREAS, the Company sponsors t

AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN)

Exhibit 10.49 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) Grant Date:      Grantee:   Units Granted:   THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T

AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN)

Exhibit 10.48 Executive Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) Grant Date:   Grantee:       Units Granted:     THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S

AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT

Exhibit 10.50 Executive Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date:  Grantee:   Units Granted:  THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Heal

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

Subsidiaries of the Registrant, as of December 31, 2025

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2025 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Interim Solutions, LLC Delaware AMN Healthcare Labor Disruption, Inc. California AMN Healthcare Language Services, Inc. Delaware A

AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT

Exhibit 10.53 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date:   Grantee:   Units Granted:     THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S E T H: WHEREAS, the Company sponsors the AM

Securities Trading Policy and Procedure

Exhibit 19.1 Securities Trading Policy and Procedure Policy Overview This policy provides the standards of AMN Healthcare Services, Inc. (the “Company” or “AMN”) on trading (as defined in Part I.F below) and causing the trading of the Company’s securities. In accordance with applicable law, all employees, officers and directors of the Company and its subsidiaries and affiliates as well as such ind

AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE)

Exhibit 10.54 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:      Grantee:   Units Granted:   THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T

AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE)

Exhibit 10.55 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:      Grantee:   Units Granted:   THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S

AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT

Exhibit 10.52 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date:      Grantee:   Units Granted:   THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S E T H: WHEREAS, the Company sponsors the A

AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT

Exhibit 10.56 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date: Grantee: Units Granted: THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee. W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthca

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2026 AMN HEALTHCARE SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 19, 2026 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS Quarterly revenue of $748 million; GAAP loss of ($0.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 30, 2026

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 30, 2026 AMN HEALTHCARE SERVICES, INC.

THE LEADER AND INNOVATOR IN TOTAL TALENT SOLUTIONS 1 Investor Presentation C o n fi d e n ti a l. P ro p e rt y o f A M N H e a lt h ca re . January 2026 C o n fi d e n ti a l. P ro p e rt y o f A M N H e a lt h ca re . 2 Non-GAAP Measures This prese

amninvestorpresentation- THE LEADER AND INNOVATOR IN TOTAL TALENT SOLUTIONS 1 Investor Presentation C o n fi d e n ti a l.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2026 AMN HEALTHCARE SER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2026 AMN HEALTHCARE SERVICES, INC.

AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corp

exhibit3112112025 AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corporation. 1.2 “Assistant Treasurer” means an Assistant Treasurer of the Corporation. 1.3 “Board” means the Board of Directors of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2025 AMN HEALTHCARE SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2025 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2025 AMN HEALTHCARE SER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2025 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2025 RESULTS Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2025 RESULTS Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 6, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 6, 2025 AMN HEALTHCARE SERVICES, INC.

FIFTH AMENDMENT TO CREDIT AGREEMENT

EXHIBIT 10.1 EXECUTION VERSION FIFTH AMENDMENT TO CREDIT AGREEMENT THIS FIFTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of October 6, 2025, is entered into among AMN Healthcare, Inc., a Nevada corporation (the “Borrower”), amn healthcare services, Inc., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identified

AMN HEALTHCARE, INC. THE GUARANTORS PARTY HERETO FROM TIME TO TIME 6.500% SENIOR NOTES DUE 2031 Dated as of October 6, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS

EXHIBIT 4.1 Execution Version AMN HEALTHCARE, INC. THE GUARANTORS PARTY HERETO FROM TIME TO TIME 6.500% SENIOR NOTES DUE 2031 INDENTURE Dated as of October 6, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 33 SECTION 1.03. Rules of Construction 34 SECTION 1.04. No Incorporation

AMN Healthcare Announces Pricing of Senior Notes Offering

EXHIBIT 99.2 AMN Healthcare Announces Pricing of Senior Notes Offering DALLAS – September 22, 2025 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031. The 2031 Notes will bear an interest rate of 6.500% pe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 22, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 22, 2025 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Launches $400.0 Million Offering of Senior Notes

EXHIBIT 99.1 AMN Healthcare Launches $400.0 Million Offering of Senior Notes DALLAS, Sept. 22, 2025 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031, subject to market and other conditions. The 2031 Notes will be guar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 22, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 22, 2025 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2025 RESULTS Quarterly revenue of $658 million and Adjusted EBITDA of $58.3 million; GAAP loss of ($3.02)/share and adjusted EPS of $0.30

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2025 RESULTS Quarterly revenue of $658 million and Adjusted EBITDA of $58.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 AMN HEALTHCARE SERVI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 7, 2025 AMN HEALTHCARE SERVICES, INC.

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:   Grantee:   Units Granted:   THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T H: W

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) Grant Date:   Grantee:   Units Granted:     THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E

Description of Securities.*

Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 AMN Healthcare Services, Inc., a Delaware corporation, has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.01 per share (“common stock”). References herein to the “Company,” “we,” “us”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2025 financial results. Financial highlights are as fol

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2025 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2025 AMN HEALTHCARE SERVICES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2025 AMN HEALTHCARE SERVICES, INC.

Filing Fee Table.

Calculation of Filing Fee Tables S-8 AMN HEALTHCARE SERVICES INC Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, par value $0.

AMN Healthcare 2025 Equity Plan.

Exhibit 10.1 AMN Healthcare 2025 Equity Plan SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS The name of the plan is the AMN Healthcare 2025 Equity Plan (as may be amended from time to time, the “Plan”). The purpose of the Plan is to encourage and enable the officers, employees, directors, and other key persons (including consultants and prospective employees) of AMN Healthcare Services, Inc.,

As filed with the Securities and Exchange Commission on May 5, 2025

As filed with the Securities and Exchange Commission on May 5, 2025 Registration No.

ARS

2025 Annual ReportDearAMNHealthcareShareholders, The ways we and our industry support the labor needs of healthcare organizations changed substantially over the past three years as providers look for innovative and tech-enabled ways to cost-effectively attract and manage a high-quality workforce that is expecting more flexible work opportunities.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.  ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

ARS/A

2024 Annual ReportUNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM10-K (MarkOne) ☒ ANNUALREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 ForthefiscalyearendedDecember31,2024 ☐ TRANSITIONREPORTPURSUANTTOSECTION13OR15(d)OFTHESECURITIESEXCHANGEACTOF1934 Forthetransitionperiodfrom to CommissionFileNo.:001-16753 AMNHEALTHCARESERVICES,INC. (ExactNameof Registrantas

AMN Healthcare Services, Inc. Securities Trading Policy.*

Exhibit 19.1 Securities Trading Policy and Procedure Policy Overview This policy provides the standards of AMN Healthcare Services, Inc. (the “Company” or “AMN”) on trading (as defined in Part I.F below) and causing the trading of the Company’s securities. In accordance with applicable law, all employees, officers and directors of the Company and its subsidiaries and affiliates as well as such ind

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2024 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Interim Solutions, LLC Delaware AMN Healthcare Labor Disruption, Inc. California AMN Healthcare Language Services, Inc. Delaware A

AMN Healthcare Services, Inc. Compensation Recoupment Policy.*

Exhibit 97.1 AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy In accordance with the applicable rules of The New York Stock Exchange (the “NYSE Rules”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) has adopted this Policy to provide for the recovery of awarded Incentive-Bas

Form of Indemnification Agreement—Officer.*

Exhibit 10.28 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this “Agreement”) is made as of , by and between AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Company”), and the individual named on the signature line below under the heading “INDEMNITEE” (“Indemnitee”). Preliminary Statements WHEREAS, the Company desires to attract and retain the services of highly qualified i

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 20, 2025 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75 DALLAS – (February 20, 2025) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 202

EX-99

EX-99 2 exhibit99.txt Exhibit 99 Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 4, 2025 AMN HEALTHCARE SERVICES, INC.

LETTER

December 16, 2024 Jeffrey R. Knudson Chief Financial Officer AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-16753 Dear Jeffrey R. Knudson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy an

AMN HEALTHCARE SERVICES, INC. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019

AMN HEALTHCARE SERVICES, INC. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 December 11, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, DC 20549 Attn: Stephen Kim and Lyn Shenk RE: AMN Healthcare Services, Inc. Form 10-K for the Fiscal Year ended December 31, 2023 File No. 001-16753 Dear Mr. Kim an

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019 November 18, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Stephen Kim and Lyn Shenk Division of Corporation Finance Office of Trade & Services Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023

AMN / AMN Healthcare Services, Inc. / Boston Partners - BOSTON PARTNERS Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* AMN HEALTHCARE SERVICES INC (Name of Issuer) Common Stock (Title of Class of Securities) 001744101 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 9, 2024 AMN HEALTHCARE SERVICES, INC.

LETTER

November 12, 2024 Jeffrey R. Knudson Chief Financial Officer AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-16753 Dear Jeffrey R. Knudson: We have reviewed your October 24, 2024 response to our comment letter and have the following comments. Please respond to this lett

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.2 Executive Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) Grant Date: Grantee: Units Granted: THIS PERFORMANCE STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.   W I T N E S S E T H: WHEREA

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.1 Executive Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT Grant Date: Grantee: Units Granted: THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made as of the Grant Date (as defined herein) by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and the Grantee.  W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcar

Fourth Amendment to Credit Agreement, dated as of November 5th, 2024, by and among AMN Healthcare, Inc., as borrow

Exhibit 4.1 EXECUTION VERSION FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of November 5, 2024, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identifi

AMN / AMN Healthcare Services, Inc. / FMR LLC Passive Investment

SCHEDULE 13G Amendment No.1 AMN HEALTHCARE SVCS INC COMMON STOCK Cusip #001744101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #001744101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 4,638,347 Item 6: 0 Item 7: 4,640,598 Item 8: 0 Item 9: 4,640,598 Item 11

AMN / AMN Healthcare Services, Inc. / FMR LLC Passive Investment

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.2 AMN HEALTHCARE SVCS INC COMMON STOCK Cusip #001744101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #001744101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 2,406,803 Item 6: 0 Item 7: 2,409,708 Item 8: 0 Ite

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 5, 2024 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2024 RESULTS Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2024 RESULTS Quarterly revenue of $688 million; GAAP EPS of $0.18 and adjusted EPS of $0.61 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2024 financial results. Financial highlights are as follows: Dol

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 October 24, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, DC 20549 Attn: Stephen Kim and Lyn Shenk Re: AMN Healthcare Services, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Form 10-Q for Fiscal Quarter Ended

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019

AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019 October 7, 2024 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Stephen Kim and Lyn Shenk Division of Corporation Finance Office of Trade & Services Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 F

AMN Healthcare Appoints Brian Scott as CFO and COO Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for More Than 10 Years

EXHIBIT 99.1 AMN Healthcare Appoints Brian Scott as CFO and COO Seasoned Healthcare Executive Brings Robust Financial Strategy Experience, Including Previous Role as Chief Financial Officer and Chief Accounting Officer of AMN for More Than 10 Years DALLAS, October 3, 2024 – AMN Healthcare Services, Inc. (NYSE: AMN) (“AMN” or “the Company”), the leader and innovator in total talent solutions for he

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 3, 2024 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 1, 2024 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Announces CFO Transition Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook

EXHIBIT 99.1 AMN Healthcare Announces CFO Transition Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook DALLAS, October 1, 2024 - AMN Healthcare Services, Inc. (NYSE: AMN) (“AMN” or “the Company”), the leader and innovator in total talent solutions for healthcare

LETTER

September 25, 2024 Jeffrey R. Knudson Chief Financial Officer AMN Healthcare Services, Inc. 2999 Olympus Boulevard, Suite 500 Dallas, TX 75019 Re: AMN Healthcare Services, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 Form 10-Q for Fiscal Quarter Ended June 20, 2024 File No. 001-16753 Dear Jeffrey R. Knudson: We have limited our review of your filing to the financial statements and relate

AMN / AMN Healthcare Services, Inc. / FMR LLC Passive Investment

SCHEDULE 13G Amendment No.0 AMN HEALTHCARE SVCS INC COMMON STOCK Cusip #001744101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #001744101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 3,815,687 Item 6: 0 Item 7: 3,819,001 Item 8: 0 Item 9: 3,819,001 Item 11

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2024 RESULTS Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2024 RESULTS Quarterly revenue of $741 million; GAAP EPS of $0.42 and adjusted EPS of $0.98 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2024 financial results. Financial highlights are as follows: D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2024 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 2, 2024 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Second Amended and Restated Certificate of Incorporation of AMN Healthcare Services, Inc.*

Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION of AMN HEALTHCARE SERVICES, INC. AMN Healthcare Services, Inc., a corporation duly incorporated under the laws of the State of Delaware, hereby certifies as follows: FIRST: The present name of the corporation is AMN Healthcare Services, Inc. (the “Corporation”). The original Certificate of Incorporation of the Corporation was fil

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2024 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2024 RESULTS Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2024 RESULTS Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2024 financial results. Financial highlights are as follows: Dol

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 19, 2024 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

ANNUAL REPORT TO SECURITY HOLDERS

Annual Report 2023 Copyright © 2024 AMN HealthcareDear AMN Healthcare Shareholders, The year 2023 began the return to normal after a global pandemic, which meant profound change for AMN Healthcare and the industry that supports the labor needs of healthcare.

DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☑ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

AMN Healthcare Services,

Exhibit 97.1 AMN HEALTHCARE SERVICES, INC. Compensation Recoupment Policy In accordance with the applicable rules of The New York Stock Exchange (the “NYSE Rules”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (the “Company”) has adopted this Policy to provide for the recovery of awarded Incentive-Bas

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.45 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equi

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.48 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - CEO (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.47 CEO Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.46 Executive Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pla

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.43 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and , (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - CEO (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.44 CEO Version AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - CEO (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.41 CEO Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), a

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.40 Executive Version AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Non-Executive (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.42 Non-Executive Form AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Pl

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2023 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Interim Solutions, LLC Delaware AMN Healthcare Language Services, Inc. Delaware AMN Healthcare Locum Tenens, Inc. Delaware AMN Hea

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 17, 2024 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Quarterly revenue of $818 million; GAAP EPS of $0.33 and adjusted EPS of $1.32

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS Quarterly revenue of $818 million; GAAP EPS of $0.33 and adjusted EPS of $1.32 DALLAS – (February 15, 2024) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2023 financi

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2024 AMN HEALTHCARE SERVICES, INC.

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0279-amnhealthcareservices.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: AMN Healthcare Services Inc Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate b

AMN / AMN Healthcare Services, Inc. / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment

SC 13G 1 amn21324.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 AMN HEALTHCARE SERVICES INC (Name of Issuer) Common Stock (Title of Class of Securities) 001744101 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to

AMN / AMN Healthcare Services, Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us0017441017012224.txt us0017441017012224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 2) AMN HEALTHCARE SERVICES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 001744101 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the approp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2023 RESULTS Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2023 RESULTS Quarterly revenue of $853 million; GAAP EPS of $1.39 and adjusted EPS of $1.97 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2023 financial results. Financial highlights are as follows: Dol

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2023 AMN HEALTHCARE SERVICES, INC.

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 23, 2023 AMN HEALTHCARE SERVICES, INC.

Monday, October 23, 2023

EXHIBIT 99.1 Date: Monday, October 23, 2023 Time: 8:00 a.m. ET Owner: Randy Reece Headline: AMN Healthcare to Acquire MSDR DALLAS, Oct. 23, 2023 (GLOBE NEWSWIRE) - AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced a definitive agreement to acquire MSDR for a purchase price of $300 million. MSDR cons

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2023 RESULTS Quarterly revenue of $991 million; GAAP EPS of $1.55 and adjusted EPS of $2.38

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2023 RESULTS Quarterly revenue of $991 million; GAAP EPS of $1.55 and adjusted EPS of $2.38 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2023 financial results. Financial highlights are as follows: D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 3, 2023 AMN HEALTHCARE SERVICES, INC.

As filed with the Securities and Exchange Commission on July 20, 2023

As filed with the Securities and Exchange Commission on July 20, 2023 Registration No.

Filing Fee Table

EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) AMN Healthcare Services, Inc.

AMN Healthcare Services Employee Stock Purchase Plan.

EXHIBIT 10.1 AMN Healthcare Services, Inc. Employee Stock Purchase Plan Adopted by the Board of Directors: March 1, 2022 Approved by the Stockholders: May 6, 2022 1. General; Purpose. (a) The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity to purchase shares of Common Stock. The Company, by means of the Plan, seeks to re

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2023 AMN HEALTHCARE SERVICES, INC.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 17, 2023 AMN HEALTHCARE SERVICES, INC.

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2023 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Third Amendment to Credit Agreement, dated as of February 10th, 2023, by and among AMN Healthcare, Inc., as borrower, the guarantors party thereto, the lenders identified on the signature pages thereto, as lenders, and Truist Bank, as administrative agent (Incorporated by reference to Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, filed with the SEC on May 5, 2023).

Exhibit 4.1 EXECUTION VERSION THIRD AMENDMENT TO CREDIT AGREEMENT THIS THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of February 10, 2023, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identifie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2023 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2023 RESULTS Quarterly revenue of $1.126 billion; GAAP EPS of $2.02 and adjusted EPS of $2.49

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2023 RESULTS Quarterly revenue of $1.126 billion; GAAP EPS of $2.02 and adjusted EPS of $2.49 DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2023 financial results. Financial highlights are as follows: D

ANNUAL REPORT TO SECURITY HOLDERS

Dear Fellow Shareholders, In many ways, the AMN Healthcare story in 2022 was about delivering in times of significant need.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

DEFINITIVE PROXY STATEMENT

Notice of Annual Meeting & Proxy Statement 2023AMN Healthcare is well positioned to continue to meet the needs of healthcare organizations in an era of workforce shortages.

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.52 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.52 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (TSR) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.54 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.54 AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (TOTAL SHAREHOLDER RETURN) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amen

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Performance) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.53 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.53 AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA PERFORMANCE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan (as may be

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2022 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Language Services, Inc. Delaware AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, L

Description of Securities (Incorporated by reference to Exhibit 4.5 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 4.5 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, AMN Healthcare Services, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (1) our common stock; (2) our preferred stock. Our common stock trades on the New York Stock Exchange under

Form of AMN 2017 Healthcare Equity Plan Restricted Stock Unit Agreement - Executive (Buy-Out) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.55 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 22, 2023).

Exhibit 10.55 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Plan, (as may be amended from time to time, the “Plan”), and desires to

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 10, 2023 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS Quarterly revenue of $1.13 billion, 4% above high end of guidance; GAAP EPS of $1.88 and adjusted EPS of $2.48

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 RESULTS Quarterly revenue of $1.13 billion, 4% above high end of guidance; GAAP EPS of $1.88 and adjusted EPS of $2.48 DALLAS – (February 16, 2023) – AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth qu

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is

AMN / AMN Healthcare Services, Inc. / BlackRock Inc. Passive Investment

SC 13G/A 1 us0017441017012623.txt us0017441017012623.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) AMN HEALTHCARE SERVICES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 001744101 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the approp

AMN / AMN Healthcare Services, Inc. / BlackRock Inc. Passive Investment

Eleventh Amended and Restated By-laws of AMN Healthcare Services, Inc. dated December 14, 2022 (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K dated December 14, 2022, filed with the SEC on December 16, 2022).

EXHIBIT 3.1 ELEVENTH AMENDED AND RESTATED BY-LAWS of AMN HEALTHCARE SERVICES, INC. (A Delaware Corporation) ARTICLE 1 DEFINITIONS As used in these By-laws, unless the context otherwise requires, the term: 1.1 “Assistant Secretary” means an Assistant Secretary of the Corporation. 1.2 “Assistant Treasurer” means an Assistant Treasurer of the Corporation. 1.3 “Board” means the Board of Directors of t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2022 AMN HEALTHCARE SERVICES, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

Severance Agreement, effective as of November 28, 2022, between AMN Healthcare, Inc. and Cary Grace (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the SEC on November 4, 2022).

Exhibit 10.2 SEVERANCE AGREEMENT THIS SEVERANCE AGREEMENT (the ?Agreement?), entered into by and between AMN Healthcare, Inc. (the ?Company?) and Cary Grace (?Executive?), is effective as of November 28, 2022 (the ?Effective Date?). 1.Employment at Will. The Company agrees to employ Executive, and Executive hereby agrees to be employed by the Company upon such terms and conditions as are mutually

Form of AMN Healthcare Equity Plan Restricted Stock Unit Agreement—Director (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the SEC on November 4, 2022).

Exhibit 10.1 AMN HEALTHCARE EQUITY PLAN RESTRICTED STOCK UNIT AGREEMENT THIS RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this DATE by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and NAME (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare Equity Plan (the ?Plan?), and desires to afford the Grantee the opportunity

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2022 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2022 RESULTS Quarterly revenue of $1.139 billion; GAAP EPS of $2.10 and adjusted EPS of $2.57

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2022 RESULTS Quarterly revenue of $1.139 billion; GAAP EPS of $2.10 and adjusted EPS of $2.57 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2022 financial results. Financial highlights are as follows: D

AMN HEALTHCARE SELECTS CARY GRACE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

EXHIBIT 99.1 NEWS RELEASE AMN HEALTHCARE SELECTS CARY GRACE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER Grace will succeed long-time leader Susan Salka in guiding company?s growth and culture DALLAS, October 31, 2022 ? AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Cary Grace as the company?s next presiden

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2022 AMN HEALTHCARE SERVICES, INC.

First Amendment to Employment Agreement, dated as of February 6, 2008, between AMN Healthcare Services, Inc. and Susan R. Nowakowski (aka Susan R. Salka) (Management Contract or Compensatory Plan or Arrangement).**

Exhibit 10.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT The Employment Agreement effective May 4, 2005 by and between AMN Healthcare Services, Inc., a Delaware corporation (the ?Company?), and Susan R. Nowakowski, an individual (the ?Executive?), is hereby amended as follows: 1.Subsection 6(a) is hereby amended by deleting the second sentence thereof and substituting therefor the following: ?In addit

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 4, 2022 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2022 RESULTS Quarterly revenue of $1.427 billion; GAAP EPS of $2.77 and adjusted EPS of $3.31

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2022 RESULTS Quarterly revenue of $1.427 billion; GAAP EPS of $2.77 and adjusted EPS of $3.31 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2022 financial results. Financial highlights are as follows:

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 10, 2022 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program

EXHIBIT 99.1 AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program DALLAS, June 15, 2022 - The Board of Directors (the ?Board?) of AMN Healthcare Services, Inc. (NYSE: AMN, the ?Company?) authorized an additional $250 million under the Company?s repurchase program for the company?s common stock (the ?Increased Company Repurchase Program?). The Company has repurchased 6.76 m

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2022 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare 2022 Senior Executive Performance and Retention Bonus Plan (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.5 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.5 AMN HEALTHCARE SERVICES, INC. 2022 PERFORMANCE AND RETENTION PLAN I. Purpose The purpose of this Plan is to provide for incentive compensation for Participants that is directly related to the 2022 Adjusted EBITDA results of the Company. This Plan provides for a potential Bonus Award payment to Participants, contingent upon continued employment and the achievement of Adjusted EBITDA th

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equit

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pl

Amendment to Restricted Stock Unit Agreements, dated as of May 5, 2022, between AMN Healthcare Services, Inc. and Jeffrey Knudson (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed with the SEC on May 6, 2022).

Exhibit 10.4 AMENDMENT TO RESTRICTED STOCK UNIT AGREEMENTS THIS AMENDMENT to RESTRICTED STOCK UNIT AGREEMENTS (the ?Amendment?) is made and entered into as of May 5, 2022, (the "Amendment Date") by and between AMN Healthcare Services, Inc. a Delaware corporation, (the ?Company?) and Jeffrey Knudson (?Grantee?). W I T N E S S E T H: WHEREAS, on November 2, 2021, Company granted Grantee restricted s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Transition Agreement, dated as of May 5, 2022, between AMN Healthcare, Inc. and Susan R. Salka (Management Contract or Compensatory Plan or Arrangement).*

Exhibit 10.3 May 5, 2022 Susan R. Salka c/o AMN Healthcare Services, Inc. Re: Transition Agreement Dear Susan: In March 2022, you informed AMN Healthcare Services, Inc. (?AMN?, and together with AMN Healthcare, Inc. and their subsidiaries, the ?Company?) that you intended to retire from your employment with the Company in 2022 following the Company?s appointment of your successor. This letter sets

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2022 RESULTS Quarterly revenue of $1.553 billion; GAAP EPS of $3.09 and adjusted EPS of $3.49

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2022 RESULTS Quarterly revenue of $1.553 billion; GAAP EPS of $3.09 and adjusted EPS of $3.49 DALLAS ? AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2022 financial results. Financial highlights are as follows: D

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 5, 2022 AMN HEALTHCARE SERVICES, INC.

DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 7, 2022 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year

EXHIBIT 99.1 AMN Healthcare Announces CEO Susan Salka Intends to Retire by End of Year DALLAS, March 10, 2022 ? AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the nation, today announced Susan Salka, its President and Chief Executive Officer, intends to retire by the end of the year upon the naming of her successor. "AMN Healthcar

Second Amendment to Office Lease, dated as of June 30, 2006, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.6 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.6 SECOND AMENDMENT TO OFFICE LEASE THIS SECOND AMENDMENT TO OFFICE LEASE ("Second Amendment") is made as of June 30, 2006, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord") and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2, 2002 (the "Office Lease"), as am

First Amendment to Office Lease, dated as of May 31, 2002, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.5 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.5 FIRST AMENDMENT TO OFFICE LEASE THIS FIRST AMENDMENT TO OFFICE LEASE ("First Amendment") is made as of May 31, 2002, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord") and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2, 2002 (the "Lease"), whereby Landlord

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2021 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Healthcare Language Services, Inc. Delaware AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, L

Fourth Amendment to Office Lease, dated as of October 5, 2021, between Kilroy Realty, L.P. and AMN Healthcare, Inc. (Incorporated by reference to Exhibit 10.9 of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on February 24, 2022).

Exhibit 10.9 FOURTH AMENDMENT TO OFFICE LEASE This FOURTH AMENDMENT TO OFFICE LEASE ("Fourth Amendment") is made and entered into as of the 5th day of October, 2021, by and between KILROY REALTY, L.P., a Delaware limited partnership ("Landlord"), and AMN HEALTHCARE, INC., a Nevada corporation ("Tenant"). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated April 2,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS Quarterly revenue of $1.36 billion, up 116% over prior year; GAAP EPS of $2.42 and adjusted EPS of $2.95

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 RESULTS Quarterly revenue of $1.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2022 AMN HEALTHCARE SERVICES, INC.

AMN / AMN Healthcare Services, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is

AMN / AMN Healthcare Services, Inc. / BlackRock Inc. Passive Investment

us0017441017012822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) AMN HEALTHCARE SERVICES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 001744101 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pu

AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference

AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 10, 2022 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 14, 2021 AMN HEALTHCARE SERVICES, INC.

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 AMN HEALTHCARE SERVICES, INC.

Lease Termination Agreement, dated as of September 9, 2021, between Kilroy Realty, L.P. and AMN Healthcare, Inc.*

EXHIBIT 10.1 LEASE TERMINATION AGREEMENT This Lease Termination Agreement (this "Agreement") is entered into as of the 9th day of September, 2021 (the ?Effective Date?), by and between KILROY REALTY, L.P., a Delaware limited partnership (?Landlord?), and AMN HEALTHCARE, INC., a Nevada corporation (?Tenant?). R E C I T A L S : A.Landlord and Tenant entered into that certain Office Lease, dated Apri

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2021 RESULTS Quarterly revenue of $878 million; GAAP EPS of $1.54 and adjusted EPS of $1.73

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2021 RESULTS Quarterly revenue of $878 million; GAAP EPS of $1.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2021 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 14, 2021 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Names Jeffrey R. Knudson as Chief Financial Officer

EXHIBIT 99.1 AMN Healthcare Names Jeffrey R. Knudson as Chief Financial Officer DALLAS, Oct. 14, 2021 ? AMN Healthcare (NYSE:AMN), the nation?s largest total talent solutions provider in healthcare, announced the appointment of Jeffrey R. Knudson as the company?s Chief Financial Officer. He will join the leadership team at AMN on November 2, 2021. Knudson resides in Dallas with his family and come

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2021 RESULTS Quarterly revenue of $857 million; GAAP EPS of $1.39 and adjusted EPS of $1.64

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2021 RESULTS Quarterly revenue of $857 million; GAAP EPS of $1.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 5, 2021 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2021 AMN HEALTHCARE SERVICES, INC.

June 16, 2021

EXHIBIT 99.1 June 16, 2021 Susan Salka AMN Healthcare Services, Inc. 8840 Cypress Waters Blvd. Coppell, TX 75019 Dear Susan: It is with mixed emotions that I am submitting my letter of resignation as the Chief Financial Officer, Chief Accounting Officer and Treasurer of AMN Healthcare, effective August 9, 2021. I joined AMN over 17 years ago and my time with the organization has not only defined m

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 17, 2021 AMN HEALTHCARE SERVICES, INC.

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement).*

EXHIBIT 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equit

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement).*

EXHIBIT 10.1 Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the ?Agreement?), made this , by and between AMN Healthcare Services, Inc. (the ?Company?), a Delaware corporation, and (the ?Grantee?). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017 Equity Pl

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 6, 2021 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2021 RESULTS Quarterly revenue of $886 million; GAAP EPS of $1.47 and adjusted EPS of $1.70

AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2021 RESULTS Quarterly revenue of $886 million; GAAP EPS of $1.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2021 AMN HEALTHCARE SERVICES, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.

- FORM DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ? Filed by the Registrant ? Filed by a Party other than the Registrant Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.

- DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

DEFA14A 1 amn3830011-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ☑ Filed by the Registrant ☐ Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ☐ Preliminary Proxy Statement ☐ Confi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) ? Filed by the Registrant ? Filed by a Party other than the Registrant CHECK THE APPROPRIATE BOX: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14

DEFINITIVE PROXY STATEMENT

AMN Overview OUR ASPIRATION We strive to be recognized as the most trusted, innovative, and influential force in helping healthcare organizations provide a quality patient care experience that is more human, more effective, and more achievable.

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant, as of December 31, 2020 Subsidiary Jurisdiction of Organization Advanced Medical Personnel Services, LLC Delaware AMN Allied Services, LLC Delaware AMN Healthcare Allied, Inc. Texas AMN Healthcare, Inc. Nevada AMN Leadership Solutions, Inc. Delaware AMN Services, LLC North Carolina AMN Staffing Services, LLC Delaware AMN Workforce Solutions, LLC Delawar

Description of Securities.*

Exhibit 4.5 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2020, AMN Healthcare Services, Inc. has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (1) our common stock; (2) our preferred stock. Our common stock trades on the New York Stock Exchange under

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVI

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS Quarterly revenue of $631 million, up 8% over prior year; GAAP EPS of $0.19 and adjusted EPS of $1.00

AMN HEALTHCARE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 RESULTS Quarterly revenue of $631 million, up 8% over prior year; GAAP EPS of $0.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2021 AMN HEALTHCARE SERVICES, INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: AMN Healthcare Services Inc. Title of Class of Securities: Common Stock CUSIP Number: 001744101 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is

SC 13G

us0017441017012521.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) AMN HEALTHCARE SERVICES INC - (Name of Issuer) Common Stock - (Title of Class of Securities) 001744101 - (CUSIP Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 11, 2021 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Announces Preliminary Fourth Quarter 2020 Revenue; To Present at J.P. Morgan Healthcare Conference

AMN Healthcare Announces Preliminary Fourth Quarter 2020 Revenue; To Present at J.

Indenture, dated as of October 20, 2020, by and among AMN Healthcare, Inc., the guarantors party thereto, and U.S. Bank National Association (Incorporated by reference to Exhibit 4.1 of the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, filed with the SEC on November 6, 2020).

Exhibit 4.1 Execution Version AMN HEALTHCARE, INC. THE GUARANTORS PARTY HERETO FROM TIME TO TIME 4.000% SENIOR NOTES DUE 2029 INDENTURE Dated as of October 20, 2020 U.S. BANK NATIONAL ASSOCIATION, as Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 31 SECTION 1.03. Rules of Construction 32 SECTION 1.04. No Incorporation by Reference o

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERV

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2020 RESULTS Quarterly revenue of $552 million; GAAP EPS of $0.55 and adjusted EPS of $0.82

AMN HEALTHCARE ANNOUNCES THIRD QUARTER 2020 RESULTS Quarterly revenue of $552 million; GAAP EPS of $0.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 5, 2020 AMN HEALTHCARE SERVICES, INC.

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 20, 2020 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Launches $325.0 Million Offering Of Senior Notes

EXHIBIT 99.1 AMN Healthcare Launches $325.0 Million Offering Of Senior Notes DALLAS - October 5, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $325.0 million aggregate principal amount of senior unsecured notes due 2029 (the “2029 Notes”), subject to market and other conditions. The 20

Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 5, 2020 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Announces Pricing of Senior Notes Offering

EXHIBIT 99.2 AMN Healthcare Announces Pricing of Senior Notes Offering DALLAS - October 5, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $350.0 million aggregate principal amount of senior unsecured notes due 2029, which represents an increase of $25.0 million from the ag

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2020 AMN HEALTHCARE SERVICES, INC.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2020 AMN HEALTHCARE SERVICES, INC.

Certain Supplemental Financial Information

EXHIBIT 99.1 Certain Supplemental Financial Information Introduction As part of our preliminary offering memorandum that is being disseminated in connection with the Notes Offering, we are providing Further Adjusted EBITDA for the twelve months ended June 30, 2020 to give effect to (i) net cost savings and synergies projected by the Company to be realized as a result of certain operational initiat

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2020 AMN HEALTHCARE SERVICES, INC.

AMN Healthcare Announces Upsize and Pricing of Senior Notes Offering

EXHIBIT 99.2 AMN Healthcare Announces Upsize and Pricing of Senior Notes Offering DALLAS and SAN DIEGO - August 10, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc. (the “Issuer”), priced its private offering of an additional $200 million aggregate principal amount of 4.625% Senior Notes due 2027, which represents an increase

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES,

AMN Healthcare Launches $150 Million Offering Of Senior Notes

EXHIBIT 99.1 AMN Healthcare Launches $150 Million Offering Of Senior Notes DALLAS and SAN DIEGO – August 10, 2020 - AMN Healthcare Services, Inc. (NYSE: AMN) (the “Company” or “AMN Healthcare”), announced today that its wholly owned subsidiary, AMN Healthcare, Inc. (the “Issuer”), intends to make a private offering of an additional $150 million aggregate principal amount of its 4.625% Senior Notes

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2020 AMN HEALTHCARE SERVICES, INC.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 6, 2020 AMN HEALTHCARE SERVICES, INC.

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RESULTS Quarterly revenue of $608 million; GAAP EPS of $0.47 and adjusted EPS of $0.83

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RESULTS Quarterly revenue of $608 million; GAAP EPS of $0.

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No.: 001-16753 AMN HEALTHCARE SERVICES

Form of Amended and Restated Severance Agreement, effective as of May 8, 2020 (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.4 AMENDED AND RESTATED SEVERANCE AGREEMENT THIS AMENDED AND RESTATED SEVERANCE AGREEMENT (the “Agreement”), entered into by and between AMN Healthcare, Inc. (the “Company”) and [EXECUTIVE] (“Executive”), was originally effective as of February 19, 2019, is amended and restated effective as of May 8, 2020 (the “Amendment Date”). 1.Employment at Will. The Company agrees to employ Executiv

Form of AMN Healthcare Equity Plan Performance Restricted Stock Unit Agreement - Non-Executive (Adjusted EBITDA Growth) (Management Contract or Compensatory Plan or Arrangement) (Incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed with the SEC on May 11, 2020).

EXHIBIT 10.2 Non-Executive Form AMN HEALTHCARE EQUITY PLAN PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (ADJUSTED EBITDA GROWTH RATE) THIS PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT (the “Agreement”), made this , 2020, by and between AMN Healthcare Services, Inc. (the “Company”), a Delaware corporation, and (the “Grantee”). W I T N E S S E T H: WHEREAS, the Company sponsors the AMN Healthcare 2017